Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Assets Average (2018 - 2025)

Neurogene (NGNE) has disclosed Assets Average for 5 consecutive years, with $306.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Assets Average rose 63.29% year-over-year to $306.3 million, compared with a TTM value of $306.3 million through Jun 2025, up 63.29%, and an annual FY2019 reading of $112.3 million, changed N/A over the prior year.
  • Assets Average was $306.3 million for Q2 2025 at Neurogene, down from $325.5 million in the prior quarter.
  • Across five years, Assets Average topped out at $325.5 million in Q1 2025 and bottomed at $172.0 million in Q3 2024.